Pure Biologics Spólka Akcyjna (PUR) — Financial Flexibility Index
Pure Biologics Spólka Akcyjna (PUR) has a Financial Flexibility Index of -0.01x as of September 2025. Free cash flow of zł-216.00K (operating CF zł-216.00K minus capex zł0.00) represents 0% of total liabilities (zł20.72 Million). Also explore PUR net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pure Biologics Spólka Akcyjna Financial Flexibility Index (2016–2024)
Historical Financial Flexibility Index trend for Pure Biologics Spólka Akcyjna across 9 annual periods. Check PUR strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Pure Biologics Spólka Akcyjna (2016–2024)
Year-by-year free cash flow to debt coverage for Pure Biologics Spólka Akcyjna. For the full company profile including market capitalisation, see PUR stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (PLN) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.70x | zł-10.83 Million | zł-10.83 Million | zł15.46 Million | ▲ +36.8% |
| 2023 | -1.11x | zł-23.09 Million | zł-23.26 Million | zł20.84 Million | ▼ -40.1% |
| 2022 | -0.79x | zł-11.63 Million | zł-17.39 Million | zł14.71 Million | ▲ +73.9% |
| 2021 | -3.03x | zł-23.36 Million | zł-24.04 Million | zł7.70 Million | ▼ -8258.0% |
| 2020 | -0.04x | zł-792.00K | zł-1.35 Million | zł21.83 Million | ▼ -109.6% |
| 2019 | 0.38x | zł5.50 Million | zł5.33 Million | zł14.57 Million | ▲ +170.7% |
| 2018 | -0.53x | zł-2.33 Million | zł-2.49 Million | zł4.36 Million | ▲ +77.8% |
| 2017 | -2.41x | zł-2.69 Million | zł-2.85 Million | zł1.12 Million | ▼ -473.2% |
| 2016 | -0.42x | zł-268.74K | zł-710.24K | zł640.12K | — |